to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
This informative piece explains a well-known method that venture capitalists use to determine "post-money valuation," which is a company's valuation at the time of investment. Perhaps more important, it provides valuable insights into why the returns expected by investors are often perceived as "too high" by entrepreneurs.
Bootstrapping allows entrepreneurs to operate their startups with minimal investments from others, according to equity capital expert, Bill Payne. This allows entrepreneurs to postpone raising capital while their firms mature and retain ownership of their companies during that time.
Timothy C. Draper is the Founder and a Managing Director of Draper Fisher Jurvetson. He was instrumental in bringing viral marketing to web-based e-mail to geometrically spread the successes of Hotmail and YahooMail, and
the practice has been adopted as a standard marketing technique by countless businesses and organizations. Draper launched the DFJ Global Network, an international network of early-stage venture capital funds with offices in over 30 cities
around the globe. He also serves on the boards of Skype, SocialText, Project Y, MailFrontier and Chroma Graphics. He was an original investor in Parametric Technology (PMTC), Tumbleweed Communications (TMWD), Overture.com (OVER),
Digidesign (AVID), Preview Travel (TVLY), Four11 (YHOO), Combinet (CSCO), and Redgate (AOL). He also founded or co-founded Wasatch Ventures (Salt Lake City), Zone Ventures (LA), Draper Atlantic (Reston), Draper Triangle (Pittsburg),
Timberline Ventures (Portland), Polaris Fund (Anchorage), Draper Fisher Jurvetson Gotham (NYC) and DFJ Frontier (Sacramento and Santa Barbara). Draper has been recognized as a leader in entrepreneurship and venture capital through numerous
awards and honors, and he has frequent TV, radio, and headline appearances. He was number seven on Forbes? Midas List and number 52 on the list of the most influential Harvard Alumni. He was also named AlwaysOn Magazine?s number one top
venture capital dealmaker for 2008. Tim is the course creator and Chairman of BizWorld, a 501c3 organization built around simulated teaching of entrepreneurship and business to children. He holds a BS in Electrical Engineering from
Stanford University, and an MBA from Harvard Business School.
Steve Perricone is President, CEO, and Co-founder of BioFuelBox Corporation. And he has over 20 years experience in the technology industry, with over half of those years in start-up environments. Perricone was Vice
President of Worldwide Sales for SonicWALL, which he joined when it had less than 20 employees. Perricone was instrumental in the growth of the company, and expanded it to over 450 employees worldwide. He was directly responsible for
building the worldwide channel for SonicWALL?s security products from the product line?s inception in 1998. That successful channel and sales organization contributed to near immediate company profitability and aggregate revenues of over
$200 million in the first three years. Prior to SonicWALL, Perricone was a senior executive in two other technology start-ups - Network TeleSystems (acquired by Siemens) and Structured Internetworks. He is an alumnus of California State
When it comes to funding for life science companies, it isn't a matter of angel investing versus venture capital. Read about funding sources for startups.
The National Institutes of Health has billions of dollars designated for biotech research. Read about how to win NIH research grants.
First-time entrepreneurs can get professional advice from accountants in this video. Topics include accounting basics such as taxes, payroll and financial records.
Read advice from a venture capitalist on how to write a business plan and avoid common mistakes in a medical business plan.
A term sheet is a complex legal document, but it's important for entrepreneurs to understand these four points when closing deals with investors.
Angel investors in the life sciences talk about when, why and how to seek angel funding for your pharmaceutical, mobile and medical device startups.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.